Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
2/4/2016
Stemline to Present at the 18th Annual BIO CEO & Investor Conference
1/5/2016
Stemline to Present at the 34th Annual J.P. Morgan Healthcare Conference
12/22/2015
Stemline Therapeutics Announces Opening of SL-801 IND
Copyright 2016 - Stemline Therapeutics, Inc. All rights reserved
Stemline